MedLife ends 2018 with EBITDA higher by 33% as compared to prior year

MedLife announces the end of 2018 with consolidated pro-forma sales of 804 million RON at group level, registering an increase of 29 % as compared to 2017.

In terms of EBITDA, the Group achieved an increase of 33% as compared to the previous period, pro-forma EBITDA reported at the level of 2018 being 103 million RON.

In terms of pro-forma sales split by business lines, clinics and the corporate division have the largest share, with 31% and 21% respectively, and it is also worth mentioning that the clinic segment had an increase of around 50% as compared to 2017.

The ranking is followed by hospitals and labs with 20% and 17% share in pro-forma sales. According to the company’s representatives, the results are in line with the initial estimates and significantly above the growth rate of the market.

“2018 was a challenging year, full of projects that focused on development through acquisitions. We have completed the Polisano transaction and brought to our group through acquisition of the majority stakes three other companies: Ghencea Medical Center, Solomed and Transilvania Imagistica, thus reaching a very good coverage of the country. At the same time, we have made an important step for a new stage of business digitization by adding to the group the largest medical information hub – sfatulmedicului.ro, “said Mihai Marcu, President and CEO of MedLife Group.

For 2019, MedLife group representatives want to maintain the dynamic pace of development. The company started the year by announcing the acquisition of the majority stake in Rozsakert Medical Center in Hungary.

“From the listing on the Bucharest Stock Exchange, after a 2015 year in which we had a turnover of 85 million Euro, we were the first private medical company in Romania that exceeded the 100 million threshold Euro reaching 176 million Euro at the end of 2018. This, coupled with the acquisition of the Rozsakert majority stake in Hungary and the new openings, gives us the hope that we will be the first to exceed the threshold of 200 million Euro in 2019 “, concluded Mihai Marcu.